Jose C. Cardoso-Silva

FEV1 is a major prognostic factor in diverse heart failure populations: findings from the Global Heart Failure registry.

Journal: ESC heart failure

Published: February 17, 2026

Heart failure in the Portuguese population aged ≥50 years: prevalence and phenotypes in the PORTHOS study.

Journal: European heart journal

Published: April 30, 2025

A Portuguese expert panel position paper on the management of heart failure with preserved ejection fraction - Part II: Unmet needs and organization of care in Portugal.

Journal: Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology

Published: November 28, 2024

Accuracy of ICD-10-PCS codes to identify Cardiac Implantable electronic devices in Portugal - A single center chart review.

Journal: International journal of medical informatics

Published: November 25, 2024

A Portuguese expert panel position paper on the management of heart failure with preserved ejection fraction - Part I: Pathophysiology, diagnosis and treatment.

Journal: Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology

Published: November 12, 2024

Real-world dapagliflozin treatment patterns in Portuguese patients with heart failure with reduced ejection fraction.

Journal: Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology

Published: September 17, 2024

Beyond clinical trials - The cost saving associated with dapagliflozin use in Portugal hospital clinical practice.

Journal: Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology

Published: February 22, 2024

Portuguese Heart Failure Prevalence Observational Study (PORTHOS) rationale and design - A population-based study.

Journal: Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology

Published: October 17, 2023

Associations of medicine use and ejection fraction with the coexistence of frailty and sarcopenia in a sample of heart failure outpatients: a cross-sectional study.

Journal: BMC cardiovascular disorders

Published: July 26, 2023

FEV1 is a major prognostic factor in diverse heart failure populations: findings from the Global Heart Failure registry.

FEV1 is a major prognostic factor in diverse heart failure populations: findings from the Global Heart Failure registry.

Heart failure in the Portuguese population aged ≥50 years: prevalence and phenotypes in the PORTHOS study.

Heart failure in the Portuguese population aged ≥50 years: prevalence and phenotypes in the PORTHOS study.

A Portuguese expert panel position paper on the management of heart failure with preserved ejection fraction - Part II: Unmet needs and organization of care in Portugal.

A Portuguese expert panel position paper on the management of heart failure with preserved ejection fraction - Part II: Unmet needs and organization of care in Portugal.

Accuracy of ICD-10-PCS codes to identify Cardiac Implantable electronic devices in Portugal - A single center chart review.

Accuracy of ICD-10-PCS codes to identify Cardiac Implantable electronic devices in Portugal - A single center chart review.

A Portuguese expert panel position paper on the management of heart failure with preserved ejection fraction - Part I: Pathophysiology, diagnosis and treatment.

A Portuguese expert panel position paper on the management of heart failure with preserved ejection fraction - Part I: Pathophysiology, diagnosis and treatment.

Real-world dapagliflozin treatment patterns in Portuguese patients with heart failure with reduced ejection fraction.

Real-world dapagliflozin treatment patterns in Portuguese patients with heart failure with reduced ejection fraction.

Beyond clinical trials - The cost saving associated with dapagliflozin use in Portugal hospital clinical practice.

Beyond clinical trials - The cost saving associated with dapagliflozin use in Portugal hospital clinical practice.

Portuguese Heart Failure Prevalence Observational Study (PORTHOS) rationale and design - A population-based study.

Portuguese Heart Failure Prevalence Observational Study (PORTHOS) rationale and design - A population-based study.

Associations of medicine use and ejection fraction with the coexistence of frailty and sarcopenia in a sample of heart failure outpatients: a cross-sectional study.

Associations of medicine use and ejection fraction with the coexistence of frailty and sarcopenia in a sample of heart failure outpatients: a cross-sectional study.

Loop diuretic discontinuation in chronic heart failure patients: A retrospective study.

Loop diuretic discontinuation in chronic heart failure patients: A retrospective study.

Global Variations in Heart Failure Etiology, Management, and Outcomes.

Global Variations in Heart Failure Etiology, Management, and Outcomes.

Mineralocorticoid receptor antagonists in cardiovascular translational biology.

Mineralocorticoid receptor antagonists in cardiovascular translational biology.